Drug Information

Drug General Information
Drug ID
D02TTL
Former ID
DCL001179
Drug Name
Debio 0932
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [550597]
Company
Debiopharm
Target and Pathway
Target(s) Heat shock protein HSP90 Target Info Inhibitor [550597]
References
Ref 550597Clinical pipeline report, company report or official report of Debiopharm (2011).
Ref 550597Clinical pipeline report, company report or official report of Debiopharm (2011).

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.